Alzheimer's disease research and diagnosis trends

Recent medical developments and reports highlight a shift in the management of Alzheimer's disease and dementia. While a full cure remains elusive, new pharmacological preparations have emerged over the last five years that can slow the progression of early-stage Alzheimer's. Experts suggest that early diagnosis and the mitigation of specific risk factors may delay symptoms or, in some instances, prevent the onset of dementia.

In Poland, approximately 600,000 people live with dementia, a figure expected to rise significantly due to an aging population. Projections from Alzheimer Europe suggest that by 2030, the number of people with dementia in Poland could reach 770,000, potentially exceeding 900,000 by 2040. Medical professionals emphasize that Alzheimer's is a disease rather than a natural part of aging, noting that many patients are diagnosed too late because cognitive impairments are often dismissed as standard aging.

The World Alzheimer Report 2026, prepared by Alzheimer's Disease International (ADI), notes that the possibility of managing the disease more effectively is more realistic than ever before. Global clinical trials are currently focused on developing more effective drugs, innovative diagnostic methods, and lifestyle strategies to improve detection and slow cognitive decline.